These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24792970)

  • 1. Reply to: "Is the pathway of energy metabolism modified in advanced cirrhosis?".
    Nagrath D; Soto-Gutierrez A
    J Hepatol; 2014 Aug; 61(2):453. PubMed ID: 24792970
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the pathway of energy metabolism modified in advanced cirrhosis?
    Ganapathy-Kanniappan S; Karthikeyan S; Geschwind JF; Mezey E
    J Hepatol; 2014 Aug; 61(2):452. PubMed ID: 24810232
    [No Abstract]   [Full Text] [Related]  

  • 3. A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.
    Nishikawa T; Bellance N; Damm A; Bing H; Zhu Z; Handa K; Yovchev MI; Sehgal V; Moss TJ; Oertel M; Ram PT; Pipinos II; Soto-Gutierrez A; Fox IJ; Nagrath D
    J Hepatol; 2014 Jun; 60(6):1203-11. PubMed ID: 24583248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
    Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
    Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the concentration of zinc in the blood and liver as measured by the neutron activation method in experimental hepatitis and cirrhosisof the liver].
    Prigozhina SM
    Eksp Khir Anesteziol; 1966; 11(4):41-5. PubMed ID: 5989335
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of mitochondrial dysfunction-related, drug-induced hepatotoxicity in primary rat hepatocytes.
    Liu C; Sekine S; Ito K
    Toxicol Appl Pharmacol; 2016 Jul; 302():23-30. PubMed ID: 27095095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.
    Kizu T; Yoshida Y; Furuta K; Ogura S; Egawa M; Chatani N; Hamano M; Takemura T; Ezaki H; Kamada Y; Nishida K; Nakaoka Y; Kiso S; Takehara T
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G613-24. PubMed ID: 25617348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrotic diseases: New tools to target an elusive integrin.
    Kingwell K
    Nat Rev Drug Discov; 2015 Jul; 14(7):460. PubMed ID: 26129800
    [No Abstract]   [Full Text] [Related]  

  • 10. One integrin to rule them all?
    Dietz HC
    Sci Transl Med; 2015 May; 7(288):288fs21. PubMed ID: 25995220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic changes in liver diseases and experimental liver damage caused by carbon tetrachloride].
    Moser K; Lujf A
    Wien Z Inn Med; 1967; 48(11):437-42. PubMed ID: 4901633
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver cancer: TGF-β and cholangiocarcinoma.
    Patman G
    Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):2-3. PubMed ID: 26669764
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial function of isolated rat hepatocytes from normal and cirrhotic liver.
    Omokawa S; Koyama K; Suzuki K; Asanuma Y
    Tohoku J Exp Med; 1989 Aug; 158(4):265-8. PubMed ID: 2588258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fuel selection.
    Müller MJ
    Proc Nutr Soc; 1995 Mar; 54(1):139-50. PubMed ID: 7568248
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury.
    Chen W; Zai W; Fan J; Zhang X; Zeng X; Luan J; Wang Y; Shen Y; Wang Z; Dai S; Fang S; Zhao Z; Ju D
    Theranostics; 2020; 10(13):5879-5894. PubMed ID: 32483425
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
    Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
    Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of glycolysis for the energetics of anoxia-tolerant and anoxia-intolerant teleost hepatocytes.
    Krumschnabel G; Manzl C; Schwarzbaum PJ
    Physiol Biochem Zool; 2001; 74(3):413-9. PubMed ID: 11331514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of methionine poisoning on energy metabolism in the guinea pig liver].
    Lescault A; Laberge C
    Union Med Can; 1974 Mar; 103(3):456-9. PubMed ID: 4820874
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the mechanism of the effect of glucose on the exagerated biosynthesis of porphyrins due to ethanol intoxication].
    Gajdos A; Gajdos-Török M
    C R Seances Soc Biol Fil; 1970; 164(4):750-4. PubMed ID: 4324503
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of long-acting superoxide dismutase on postischemic liver injury in rats with cirrhosis.
    Kurokawa T; Nonami T; Kobayashi H; Sugiyama S; Ozawa T; Takagi H
    J Hepatol; 1992 May; 15(1-2):268-9. PubMed ID: 1506650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.